There are 2789 resources available
137P - Trial comparing the safety, efficacy and immunogenicity of trastuzumab biosimilar candidate (TX05) with originator trastuzumab in HER2+ early breast cancer
Presenter: Peter Krivorotko
Session: ePoster Display
185P - Receipt of neoadjuvant treatment (NADJ) and impact of types of surgery on health-related quality of life (HRQoL) among patients (pts) with early stage HR+/HER2- breast cancer (BC)
Presenter: Alex Rider
Session: ePoster Display
186P - Long-term follow-up results of intensity modulated radiotherapy in early-stage breast cancer patients
Presenter: Zita Zolcsak
Session: ePoster Display
187P - Relationship between immune profile and immunophenotype in early breast cancer
Presenter: Celia María Bravo
Session: ePoster Display
188P - Amelioration of anxiety, depression, and chemotherapy related toxicity after crocin administration during chemotherapy of breast cancer: A double blind, randomized clinical trial
Presenter: Seyed Alireza Javadinia
Session: ePoster Display
189P - Invasive lobular carcinoma in young breast cancer patients: Incidence and clinicopathological characteristics
Presenter: Abeid Athman Omar
Session: ePoster Display
190P - Clinical features and recurrence-free survival among young patients with breast cancer
Presenter: Andrea Becerril-Gaitan
Session: ePoster Display
249P - The CDK4/6 inhibitors takeover of the HR+/HER2- locally advanced to metastatic breast cancer market in the EU5: Findings from a real-world study
Presenter: Pierre-Olivier Graff
Session: ePoster Display
259P - Weekly ladiratuzumab vedotin monotherapy for metastatic triple-negative breast cancer
Presenter: Michaela Tsai
Session: ePoster Display